Prostate cancer trials in Guatemala

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  Where

  Guatemala City

  Age

  18 years and over

  People

  1,440 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06925737 · EU 2024-517423-40-00
• Phase 3Taking people
  A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  Where

  Guatemala City

  Age

  18 years and over

  People

  1,314 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06136650 · EU 2023-504957-11-00